Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0578320180410040320
Molecules and Cells
2018 Volume.41 No. 4 p.320 ~ p.330
¥ä-Catenin Increases the Stability of EGFR by Decreasing c-Cbl Interaction and Enhances EGFR/Erk1/2 Signaling in Prostate Cancer
Shrestha Nensi

Shrestha Hridaya
Ryu Tae-Yong
Kim Han-Gun
Simkhada Shishli
Cho Young-Chang
Park So-Yeon
Cho Sa-Yeon
Lee Kwang-Youl
Lee Jae-Hyuk
Kim Kwon-Seop
Abstract
¥ä-Catenin, a member of the p120-catenin subfamily of armadillo proteins, reportedly increases during the late stage of prostate cancer. Our previous study demonstrates that ¥ä-catenin increases the stability of EGFR in prostate cancer cell lines. However, the molecular mechanism behind ¥ä-catenin-mediated enhanced stability of EGFR was not explored. In this study, we hypothesized that ¥ä-catenin enhances the protein stability of EGFR by inhibiting its lysosomal degradation that is mediated by c-casitas b-lineage lymphoma (c-Cbl), a RING domain E3 ligase. c-Cbl monoubiquitinates EGFR and thus facilitates its internalization, followed by lysosomal degradation. We observed that ¥ä-catenin plays a key role in EGFR stability and downstream signaling. ¥ä-Catenin competes with c-Cbl for EGFR binding, which results in a reduction of binding between c-Cbl and EGFR and thus decreases the ubiquitination of EGFR. This in turn increases the expression of membrane bound EGFR and enhances EGFR/Erk1/2 signaling. Our findings add a new perspective on the role of ¥ä-catenin in enhancing EGFR/Erk1/2 signaling-mediated prostate cancer.
KEYWORD
¥ä-Catenin, c-Cbl, EGFR, ubiquitination
FullTexts / Linksout information
Listed journal information
SCI(E) MEDLINE ÇмúÁøÈïÀç´Ü(KCI)